Peptide therapy is generally well-tolerated when administered under professional supervision
Factors that may influence perioperative management include: Medication characteristics : Daily GLP-1 medications (liraglutide, oral semaglutide) have shorter durations of action than weekly formulations (injectable semaglutide, dulaglutide, exenatide extended-release) [3] Risk factors : Higher doses, recent dose increases, active gastrointestinal symptoms, or known gastroparesis may increase risk [1] [3] Procedure type : More complex surgeries or those requiring general anaesthesia may warrant different approaches than minor procedures Individual patient factors : BMI, presence of diabetes, and other medical conditions Some anaesthetists may recommend temporarily pausing GLP-1 therapy before certain procedures, particularly for patients with additional risk factors
82 MadsenKKnudsenLBAgersoeHNielsenPFThgersenHWilkenMet al
If you are participating in a clinical trial and experience a suspected side effect, you should report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Wegovy is one of the weight loss medications offered through the Juniper Programme to see if you're eligible, simply take our online quiz